Word

MPROTECT-IM

Status

Dead

Status Code

606

Status Date

Monday, March 4, 2024

Serial Number

97486016

Mark Type

4000

Filing Date

Friday, July 1, 2022

Published for Opposition

Tuesday, December 6, 2022

Abandoned Date

Monday, March 4, 2024

Trademark Owner History

ModernaTx, Inc. - Owner At Publication

Classifications

5 Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing messenger RNA for preventing and treating viruses, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, and respiratory disorders; mRNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ prevention and treatment of viruses rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, and respiratory disorders; lipid nanoparticles for pharmaceutical, medical or diagnostic purposes; drug carriers for medical use, namely, lipid nanoparticles for delivering drugs; lipid nanoparticles for drug delivery sold as an integral component of drugs; pharmaceutical preparations, namely, messenger RNA and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells

1 Medical, biological, and pharmaceutical preparations for scientific, research, medical laboratory use, or for the manufacture of pharmaceuticals, namely, preparations containing messenger RNA for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, and metabolic disorders,; biochemicals for in vivo, ex vivo, or in vitro scientific research and medical research, namely, for use in the manufacture of pharmaceuticals for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders,; lipid nanoparticles for scientific, laboratory or medical research use

42 Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines

M PROTECT IM

Trademark Events

Mar 4, 2024

Abandonment Notice E-Mailed - No Use Statement Filed

Mar 4, 2024

Abandonment - No Use Statement Filed

Aug 30, 2023

Teas Change Of Correspondence Received

Aug 30, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 30, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 30, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Aug 30, 2023

Teas Change Of Owner Address Received

Aug 10, 2023

Teas Change Of Correspondence Received

Aug 10, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 10, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 10, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Aug 10, 2023

Teas Change Of Owner Address Received

Jun 6, 2023

Notice Of Approval Of Extension Request E-Mailed

Jun 2, 2023

Sou Extension 1 Granted

Jun 2, 2023

Sou Extension 1 Filed

Jun 2, 2023

Sou Teas Extension Received

Jan 31, 2023

Noa E-Mailed - Sou Required From Applicant

Dec 6, 2022

Official Gazette Publication Confirmation E-Mailed

Dec 6, 2022

Published For Opposition

Nov 16, 2022

Notification Of Notice Of Publication E-Mailed

Nov 2, 2022

Approved For Pub - Principal Register

Oct 8, 2022

Assigned To Examiner

Jul 21, 2022

New Application Office Supplied Data Entered

Jul 5, 2022

New Application Entered